Growth Vybz

Growth Vybz Food Services and Catering Business Growth Specialist for last 15 years! From idea to success story!

🇱🇹 In 2025, Lithuania ranked among the TOP EU countries for life-sciences export intensity — yet most HealthTech startup...
31/01/2026

🇱🇹 In 2025, Lithuania ranked among the TOP EU countries for life-sciences export intensity — yet most HealthTech startups here still fail to convert pilots into cross-border revenue.

That gap is not about talent or technology.
It’s about export-readiness by design.

Lithuania has:
• export-grade diagnostics and CDMOs
• EU-connected health data infrastructure
• strong clinical validation capacity

Yet many founders still build local pilots that die locally.

So I mapped what actually scales from Lithuania into the EU 👇

🇱🇹 The Lithuania HealthTech Export Stack (what converts, not what demos)

1️⃣ Lab Diagnostics: Where credibility is created
- Lithuania’s unfair advantage is QA-ready validation, not “early pilots”.
- Northway Biotech · Thermo Fisher (Vilnius) · Biomapas · Biotechpharma · Santaros Klinikos labs · LSMU · Vilnius University Life Sciences Center · Eurofins · SYNLAB
- Action: Design pilots that survive regulatory + buyer scrutiny, not just clinical interest.

2️⃣ Data Infrastructure: Where scale usually breaks
- Lithuania is already wired into EU health data rails — most startups just ignore them.
- eSveikata · HL7 Lithuania · openEHR · SNOMED · LOINC · MyHealth@EU · InterSystems IRIS · SAP Health Data Services
- Action: If you’re not FHIR-ready from day one, expansion will cost you 6–12 months later.

3️⃣ Care Platforms: Where revenue actually shows up
- This is where Lithuania-based companies prove monetization, not just adoption.
- Kilo Health · TeltoHeart (Teltonika) · Doctolib · Kry/Livi · Doctorly · Ada · Infermedica · Huma · Luscii · Current Health
- Action: Anchor to a buyer rail (employer, provider group, payer) — not just users.

4️⃣ Scale Enablers: Where contracts are unlocked
- quietly excels here — founders just don’t sequence it correctly.
- · Startup Lithuania · LithuaniaBIO · Lab · Tech Park · STP · EIT Health · Startup Wise Guys · Baltic Sandbox Ventures
- Action: Use these as go-to-market accelerators, not pitch-deck logos.

More than 300,000 people in are living with — and -related care is now one of the fastest-growing cost pressures f...
09/01/2026

More than 300,000 people in are living with — and -related care is now one of the fastest-growing cost pressures for regional budgets.

That single fact explains why Denmark is moving so aggressively toward remote diabetes & obesity care — and why many startups still fail to convert pilots into real contracts.

I see the same mistake repeatedly:
Founders try to sell a great product into a market that actually buys systems.

That’s why I mapped Denmark’s Remote Diabetes & Obesity Care Stack — and why I built a free tool to help startups assess whether they’re actually deployable inside it.

Here’s how the system really works 👇

1️⃣ Anchors
- This is where trust and decision-making start — not procurement teams.
- Think Steno Diabetes Center (Odense, Aarhus), Rigshospitalet, OUH, Aarhus & Aalborg University Hospitals, SDU, Hvidovre, Herlev, Gentofte.

If your solution isn’t legible to these actors, it won’t scale.

2️⃣ Data Infrastructure
- This is the biggest silent blocker.
- Denmark runs on national data rails like sundhed.dk, Fælles Medicinkort, Sundhedsplatformen, MedCom, with integrators like Systematic, NNIT, KMD, Tietoevry, Trifork, CGI.

No clean fit here = no deployment, regardless of outcomes.

3️⃣ Remote Monitoring
- This is how regions reduce follow-ups and free clinical capacity.
- Dexcom, Abbott, Medtronic, Roche, Ypsomed, Ascensia, Insulet, Huma, Luscii, Philips HealthSuite, Omron, Withings, Biofourmis.

Regions don’t want “more data” — they want decision-grade signals.

4️⃣ Lifestyle
- This is where outcomes (and ROI) are actually created.
- Sidekick, Liva, Noom, Oviva, Second Nature, Welldoc, Virta, Dario, Lark, Sweetch, Headspace, MyFitnessPal, Lenus, Wellhub.

Engagement metrics don’t close contracts.
Outcome economics do.

In 2025, remains the most breached industry in the US — and buyers are reacting. Multiple M&A advisors and cyber insur...
28/12/2025

In 2025, remains the most breached industry in the US — and buyers are reacting.

Multiple M&A advisors and cyber insurers now confirm that gaps are one of the top non-financial reasons healthcare deals get repriced, delayed, or killed.

That’s the shift most founders still underestimate.
Cybersecurity is no longer an IT issue.
It’s a valuation, timing, and exit issue.

Over the last year, I kept seeing the same pattern:
great product, real , serious buyer interest — and then the deal stalls because security diligence turns into a red flag instead of a checkbox.

So I mapped what investors are actually looking for.

The 4-Layer Cyber Stack Behind Every Healthcare Deal (Dec 2025)
This is the system buyers implicitly use — whether they say it or not:

1) Risk Mapping — “What’s actually at risk?”
If you can’t clearly map PHI/PII flows, access points, and exposure scenarios, buyers assume the worst.
Clearwater , Fortified Health Security, Optiv, GuidePoint, Kroll, Mandiant, CrowdStrike, Rapid7, Arctic Wolf

2) & Controls — “Is this defensible in diligence?”
This is where / readiness turns into deal velocity (or friction).
HITRUST, , , Vanta, , , Wiz, ,

3) Buyer Trust — “Does security unblock revenue?”
Weak security = stalled hospital procurement and lost enterprise deals.
, Ping, CyberArk, , Netskope, , Elastic Security, GRC, AWS Security Hub

4) Transaction Protection — “How do investors hedge downside?”
Uninsurable risk often becomes uninvestable risk.
, , AIG Cyber, XL, Coalition, At-Bay, Marsh, Aon, Willis Towers Watson

This isn’t about buying more tools. It’s about sequencing:
• Week 1: Risk mapping + buyer-ready security narrative
• Weeks 2–3: Audit-ready controls and evidence
• Weeks 3–5: Procurement pack + monitoring + incident tabletop
• Weeks 5–6: Insurance readiness + deal protection

ROI founders care about: faster , fewer diligence stalls, lower valuation haircut risk, higher close probability.

If you are or selling in HealthTech, you can't be everywhere. You need to be where the deal flow is.I mapped the criti...
27/12/2025

If you are or selling in HealthTech, you can't be everywhere. You need to be where the deal flow is.

I mapped the critical events from Oct 2025 to May 2026 so you don't have to guess.

👇 SAVE THIS LIST 👇

🏛️ Midwest: Where clinical validation happens. Look for: Cleveland Clinic Innovations, MedCity INVEST, BioMidwest.

🚀 West Coast: Where tech meets venture. Look for: Stanford Medicine, UCSF Health Hub, AWS Health Symposium.

🧬 East Coast: Where pharma and paying systems live. Look for: MassBio, Startup Health, AI in Healthcare Summit.

🤠 South/Southwest: The rapid growth engines. Look for: TMC Innovation, SXSW, BioHouston.

Here is the reality check: Investment hit $10.2B in Q3. But simply showing up isn't a strategy. Most founders wait too long to follow up and let the momentum die.

My Rule: If a lead isn't contacted in 72 hours, it didn't happen.
I use a specific framework to track CPL (Cost Per Lead) and Payback speed for every single conference.

Want to see how it works? DM me “ROI MAP” and I’ll share my event conversion checklist. 🚀

Address

Vilnius

Website

Alerts

Be the first to know and let us send you an email when Growth Vybz posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Growth Vybz:

Shortcuts

Share

Category